Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10157740 | Pathology - Research and Practice | 2018 | 26 Pages |
Abstract
Our study provided evidence that serum miR-130b level may be used as an ideal marker for monitoring the recurrence and prognosis of PHC after RFA treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiang-Yu Hu, Li Li, Hong-Tao Wu, Ying Liu, Bei-Da Wang, Ying Tang,